Author:
Diener H.C.,Evers S.,Gendolla A.
Reference22 articles.
1. The adverse event and tolerability profile of zolmitriptan;Edmeads;Rev Contemp Pharmacother,2000
2. Tolerability profile of zolmitriptan (Zomig™; 311C90), a novel dual central and peripherally acting 5HT1B/1D agonist. International experience based on >3000 subjects treated with zolmitriptan;Edmeads;Cephalalgia,1997
3. Zolmitriptan in the acute treatment of migraine: an overview;Goadsby;Rev Contemp Pharmacother,2000
4. The clinical efficacy of zolmitriptan;Nappi;Rev Contemp Pharmacother,2000
5. Zolmitriptan (Zomig™, 311C90), a novel dual central and peripheral 5HT1B/1D agonist: an overview of efficacy;Schoenen;Cephalalgia,1997